Search Within

Nadeem Abu-Rustum

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (20)
Groups
  1. Department of Medicine (53)
  2. GDMT, Surgery (53)
  3. Gynecology Disease Management Team (53)
  4. Hematologic Malignancies, Division of (53)
  5. Surgery (53)
  6. Solid Tumor Oncology Division (51)

More Groups

People
  1. Roisin O'Cearbhaill (47)
  2. Yukio Sonoda (37)
  3. Dennis Chi (30)
  4. Kara Long Roche (29)
  5. Oliver Zivanovic (26)
  6. Ginger Gardner (25)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (8)
  6. 2020 (6)

More Years

Publications
  1. Gynecologic Oncology (25)
  2. International Journal of Gynecological Cancer (11)
  3. Journal of Clinical Oncology (5)
  4. Gynecologic Oncology Reports (3)
  5. Annals of Oncology (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (26)
  2. Lippincott Williams & Wilkins (12)
  3. American Society of Clinical Oncology (6)
  4. Elsevier B.V. (3)
  5. American Association for Cancer Research (1)
  6. Cell Press (1)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
    Journal Article

    Basaran, D.; Boerner, T.; Suhner, J.; Sassine, D.; Liu, Y.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Quaternary and beyond cytoreduction: An updated and expanded analysis
    Journal Article

    Manning-Geist, B. L.; Chi, D. S.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; O'Cearbhaill, R. E.; Abu-Rustum, N. R.; Leitao, M. M. Jr
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer
    Meeting Abstract

    Lim, S.; Moss, H.; Havrilesky, L.; O'Cearbhaill, R.; Abu-Rustum, N.; Liang, M.; Wright, J.; Aviki, E.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis
    Journal Article

    Manning-Geist, B. L.; Chi, D. S.; Long Roche, K.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; O'Cearbhaill, R. E.; Abu-Rustum, N. R.; Leitao, M. M. Jr
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Pattern of disease and response to pembrolizumab in recurrent cervical cancer
    Journal Article

    Miller, K. M.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N. R.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Selenica, P.; Jewell, E. L.; Kyi, C.; more...
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary study
    Journal Article

    Boerner, T.; Walch, H. S.; Nguyen, B.; Iasonos, A.; Zhou, Q. C.; Schultz, N.; Chui, M. H.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Boerner, T.; Tanner, E.; Filippova, O.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; O'Cearbhaill, R. E.; Grisham, R. N.; Gardner, G. J.; Sonoda, Y.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab
    Meeting Abstract

    Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: What is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; O'Cearbhaill, R.; Konner, J. A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Serous tubal intraepithelial carcinoma (STIC) at the time of primary debulking surgery (PDS) of high-grade serous ovarian cancer (HGSOC): Does it matter?
    Meeting Abstract

    Boerner, T.; Chi, A.; Zivanovic, O.; Soslow, R. A.; Sonoda, Y.; Gardner, G. J.; Leitao, M. M.; Tew, W. P.; Konner, J.; Grisham, R. N.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save